About Blackstone Group
Blackstone is one of the world’s largest alternative asset managers, headquartered in New York, with healthcare exposure spanning private equity, real estate, growth, and life sciences. Its private equity activity in healthcare touches care delivery, tech-enabled services, life sciences tools, and healthcare real estate. Blackstone is structurally not an early-stage AI investor, though Blackstone Growth and Blackstone Life Sciences engage in later-stage transactions.
Check sizes are $25M and above, with most healthcare deals running into the hundreds of millions or billions. Deployment is global. The firm engages at scale, often through control buyouts, public-to-private transactions, or large minority growth rounds. Specific named portfolio companies in the healthcare AI segment are not provided in the source data.
Blackstone is not a meaningful target for the vast majority of healthcare AI founders. Anyone below roughly $50M+ revenue should not pitch. The relevant moment is when a company is approaching public scale or running a banker-led process. Until then, founders should focus their time elsewhere.
Founder reviews
Healthcare AI tools backed by Blackstone Group
Tools made by companies in Blackstone Group's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Blackstone Group's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from Blackstone Group? Founders only — share your honest experience (anonymous OK, moderated before publishing).